Defining the right diluent for intravenous infusion of therapeutic antibodies

Therapeutic monoclonal antibodies (mAbs) are commonly administered to patients through intravenous (IV) infusion, which involves diluting the medication into an infusion solution (e.g., saline and 5% dextrose). Using the wrong diluent can cause product aggregation, which may compromise patient safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Shen, McSweeney, Keisha Melodi, Wang, Tao, Bacot, Silvia M., Feldman, Gerald M., Zhang, Baolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927757/
https://www.ncbi.nlm.nih.gov/pubmed/31774346
http://dx.doi.org/10.1080/19420862.2019.1685814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927757/
https://www.ncbi.nlm.nih.gov/pubmed/31774346
http://dx.doi.org/10.1080/19420862.2019.1685814

Ejemplares similares